Polar Body Cooling Products

Do you have a body
cooling problem?
sponsor!
MS Views & News

Shared MS Resources
~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~

===================
MS Neuro Ratings
Read Reviews of MS Neurologists
===================
Revive MS Support
Over 10,000 people in Scotland (1 in 500) have MS, the highest prevalence of any country in the world.
Disability Connections
Dedicated to enhancing the daily lives of those coping with physical
challenges, mobility issues, and other types of medical disabilities.
We connect people to resources and services.
Click above
====================
====================
FOR PEOPLE WITH MS AND THEIR SUPPORT PARTNERS
EasyStand - Standing Frames
===================
MyMS>myWay
| New Theory proposes that multiple sclerosis is a vascular disease that can be addressed with surgery |
|
|
|
|
University of British Columbia plans to test potentially groundbreaking MS treatment
----------------------------------------------------------------------
Jane Armstrong Vancouver — From Wednesday's Globe and MailPublished on Tuesday, Dec. 15, 2009 9:17PM ESTLast updated on Wednesday, Dec. 16, 2009 5:30AM EST
The University of British Columbia has announced plans to begin patient trials to test a potentially groundbreaking method of diagnosing and treating multiple sclerosis, a disease that afflicts up to 75,000 Canadians. Researchers have proposed launching a study involving 100 patients to test a theory that MS is a vascular disease that can be treated with surgery. It's the first research proposal in Canada to suggest evaluating the findings of an Italian doctor whose early studies indicate that multiple sclerosis might be caused by vein blockages that lead to a buildup of iron in the brain. The findings of Paolo Zamboni have generated a great deal of interest among researchers and those with MS. Earlier this year, the Multiple Sclerosis Society of Canada appealed to scientists to follow up Dr. Zamboni's theories. The proposed UBC trial, which would be done in collaboration with researchers at the University of Saskatchewan, is an answer to that appeal, said Anthony Traboulsee, medical director of the UBC MS Clinic. Continue reading at our MS Blog: Stu's Views and MS News. Leave Comments please, at our blog posting.
|
| Last Updated on Saturday, 27 February 2010 20:31 |
MS Views & News
Event List - Calendar
Member Log-in or Registration
Tysabri Information
Shared resources
LDN RESEARCH TRUST
Low-dose Naltrexone (LDN) has
been used in the treatment of
autoimmune diseases in the USA
since 1985 with few initial side
effects.

.........................................
Puerto Rico MS Society


.........................................














![[image]](http://i113.photobucket.com/albums/n225/thehappyhusky/LogoBlend11.jpg)















